Corticotropin-releasing hormone (CRH) exerts an anti-inflammatory effect indirectly, via cortisole production, and a proinflammatory effect directly on immune cells. The aim of the present work was to examine the effect of CRH on macrophage-derived cytokines both in vitro and in vivo. For the in vitro experiments we used two types of macrophages: (i) the RAW264.7 monocyte/macrophage cell line and (ii) thioglycolate-elicited peritoneal macrophages from BALB/c mice. We have found that CRH enhanced lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNF-␣), interleukin-1 (IL-1), and IL-6 production. For the in vivo experiments we have used the LPS-induced endotoxin shock model in BALB/c mice, an established model for systemic inflammation in which macrophages are the major source of the proinflammatory cytokines responsible for the development of the shock. Administration of antalarmin, a synthetic CRH receptor 1 (CRHR1) antagonist, prior to LPS prolonged survival in a statistically significant manner. The effect was more evident at the early stages of endotoxin shock. CRHR1 blockade suppressed LPS-induced elevation of the macrophagederived cytokines TNF-␣, IL-1, and IL-6, confirming the role of CRH signals in cytokine expression. In conclusion, our data suggest that CRH signals play an early and crucial role in augmenting LPS-induced proinflammatory cytokine production by macrophages. Our data suggest that the diffuse neuroendocrine system via CRH directly affects the immune system at the level of macrophage activation and cytokine production.Corticotropin-releasing hormone (CRH) affects the immune system. This effect can be indirect, via the end products of the two major axes of the adaptive response to stress, regulated by CRH, i.e., cortisole of the hypothalamus-pituitary-adrenals (HPA) axis and catecholamines of the sympathetic system (13). CRH also affects the immune system in a direct manner. Indeed, CRH is released at the site of inflammation by nerve terminals and epithelial cells, affecting resident immune cells (13,33). It should be noted that while the indirect effect of CRH is anti-inflammatory, its direct paracrine effect is definitely proinflammatory. Thus, blockade of its paracrine effect by specific anti-CRH serum attenuates the inflammatory response in several models of inflammation in vivo (15, 33). A major immune target of CRH is the mast cell (13, 25). However, in addition to mast cells a growing list of immune cells exhibits specific CRH binding sites. Thus, mouse splenocytes (34), human peripheral blood monocytes and lymphocytes (24), and monocytes/macrophages and Th cells (2) have CRH receptors. CRH receptors are also present in inflamed synovium (9) and inflamed subcutaneous tissues (19). CRHR1 expression is upregulated by lipopolysaccharide (LPS) stimulation (22). The aim of the present work was to study the effect of CRH on macrophages, the main source of the proinflammatory cytokines tumor necrosis factor alpha (TNF-␣), interleukin-1 (IL-1), and IL-6, which initiate the in...